Empyrean Capital Partners’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Empyrean Capital Partners’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-550,000	Closed	-$5.38M	–	142
2022 Q2	$5.38M	Hold	550,000	–	–	0.17%	107
2022 Q1	$5.37M	Buy	550,000 +50,000	+10%	+$486K	0.12%	124
2021 Q4	$4.86M	Hold	500,000	–	–	0.13%	123
2021 Q3	$4.85M	Buy	+500,000	New	+$4.85M	0.11%	128

Other funds holding AONC

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Empyrean Capital Partners's AONC Position: Q3 2022 in Review

Empyrean Capital Partners sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q3 2022, closing a stake of 550,000 shares — an estimated $5.38M sold.

Empyrean Capital Partners first reported a position in AONC in Q3 2021 and held it in 4 quarters. The position peaked at $5.38M in Q2 2022. 74 funds tracked by Wall St. Rank hold AONC as of Q3 2022.

Empyrean Capital Partners reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Empyrean Capital Partners sold 550,000 American Oncology Network, Inc. Class A Common Stock shares in Q3 2022, an estimated $5.38M.
Empyrean Capital Partners first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 4 quarters.
Empyrean Capital Partners's American Oncology Network, Inc. Class A Common Stock position peaked at $5.38M in Q2 2022.
74 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q3 2022.

Based on Empyrean Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.